Condition
CNS Tumor, Childhood
Total Trials
4
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (2)
P 2 (1)
Trial Status
Recruiting3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07243470Phase 1Recruiting
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
NCT06104488Phase 1Recruiting
A Study of Avutometinib for People With Solid Tumor Cancers
NCT04479514Phase 2Completed
Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy
NCT06380387Not ApplicableRecruitingPrimary
Whole Body Metabolism in Children Before and After Treatment of CNS Tumor
Showing all 4 trials